Oral & DentalLLLT enhanced bone remodeling by stimulating both bone formation and resorption, resulting in accelerated orthodontic tooth movement.
Trial · November 10, 2026 · Lazăr L et al.
Oral & DentalMost trials carried a high or unclear risk of bias, and treatment protocols were heterogeneous. Larger trials with standardized dosimetry are needed to establish the clinical value of PBM therapy at the palatal donor site.
Review · November 7, 2026 · Chu Thi Quynh H et al.
Eye, Ear & VisionShortened tear film break-up time (TBUT) independently causes refractive prediction error. Each 1-s TBUT increase raises the odds of target refraction nearly fivefold, with a ≥ 6-s clinical threshold.
Study · November 3, 2026 · Jiao ZX et al.
Devices & DosimetryExtending the in vitro findings, in vivo experiments using hTNF-α transgenic mice showed that PBMT enhanced the immunostaining signals of SIRT1 and PGC-1α in joint tissues.
Study · October 30, 2026 · Li X et al.
Oral & DentalOver 48 weeks, PBM + SM and OS + SM produced comparable improvements in pain and maximum painless mouth opening, with no significant between-group difference in masticatory muscle tender points at week 48.
Trial · October 27, 2026 · Hoa NN et al.
Eye, Ear & VisionRLRL therapy was associated with AL stabilization in highly myopic eyes.
Study · October 22, 2026 · Isomura N et al.
Oral & DentalThe combined use of aPDT and PBMT with the described laser parameters seemed to be a promising, conservative and effective approach to optimize root canal disinfection, promoting local analgesy and possible accelerating apical bone remodeling.
Study · October 21, 2026 · Scatena DA et al.
Brain & NeurologyFurthermore, we evaluate how the integration of optogenetic tools and nanomaterials has refined NIR therapies, establishing a foundation for high-precision neurology.
Review · October 17, 2026 · Li X et al.
Devices & DosimetryHowever, considerable variations in laser parameters and treatment protocols limit the comparability of findings across studies and make it difficult to draw definitive conclusions.
Review · October 15, 2026 · Katara A et al.
Brain & NeurologyConclusionThese findings suggest that short-term tPBM targeting the SMA can enhance motor performance, particularly of the non-dominant hand, and increase sensorimotor alpha and beta power in healthy young adults.
Study · October 12, 2026 · Iravani M et al.
OtherThe implications of these optical characteristics for tissue photobiomodulation are discussed based on previous studies.
Study · October 8, 2026 · Lee CM et al.
Devices & DosimetryThey should not be extrapolated to photobiomodulation, other laser modalities, or other disease stages. Independent randomised evidence is required before its effectiveness can be established.
Review · October 6, 2026 · Xamza M et al.
Safety & EvidenceMore importantly, a candlelight-like emission with a CCT of 1855 K and a high spectral resemblance index of 92.4% is simultaneously achieved in the resulting device.
Study · October 1, 2026 · Wang Y et al.